BLOOM Research Journal
24 original guides: one for every compound in the catalogue, plus frameworks for reading studies, comparing listings, planning storage and checking Canadian product information.
Featured guide
A tiering framework for peptide literature, with worked examples of what each study type can and cannot support.
Understanding evidence · 2 min read
Read the guideUnderstanding evidence
Three tiers of peptide evidence
23 guides
Documentation
Learn how to trace a Canadian trial from Health Canada's portal to its registry and published paper, compare outcomes, and separate trial from product authorization.
Understanding evidence
Understand peptide adsorption to sample containers, its limits in laboratory evidence, and the records that help distinguish calculated concentration from recovery.
Documentation
A practical pre-purchase checklist for comparing research-material listings, records and identifiers.
Documentation
How to read a certificate of analysis without treating one result as proof of everything.
Storage
A documentation-first storage plan that keeps product-specific instructions in control.
Canada
How to use Health Canada’s Drug Product Database without confusing an ingredient match with product authorization.
Comparisons
A side-by-side framework for comparing what a listing actually says before comparing price.
Compound guides
A plain-language guide to BPC-157 as an experimental peptide studied in tissue-repair models, and the limits of that work.
Compound guides
What mouse wound-healing research on thymosin beta-4 shows, and why a TB-500 label needs supplier confirmation.
Compound guides
What published retatrutide research reported, why it is informally called GLP-3, and why GLP-3 is not a receptor name.
Compound guides
What the CJC-1295 and ipamorelin literature reports separately, and what a 10 mg blend listing leaves unspecified.
Compound guides
How to read a BPC-157 and TB-500 blend listing when the cited research examined each component separately.
Compound guides
What the 2007 tesamorelin trial measured, why visceral fat is not general weight loss, and what that excludes.
Compound guides
How official labelling describes semaglutide’s GLP-1 receptor mechanism, what STEP 1 measured, and the limits of both.
Compound guides
What US bremelanotide labelling states about mechanism, indication and adverse effects , and what it excludes.
Understanding evidence
What the receptor names in metabolic peptide research refer to, and why the informal GLP-3 name for retatrutide is not a receptor name.
Understanding evidence
How to reason about a multi-component listing when the published studies examined the components separately.
Understanding evidence
Four questions that turn a study abstract into a sentence you can actually defend.
Documentation
A worksheet for checking whether a certificate of analysis genuinely belongs to the vial in front of you, and what verification cannot settle.
Understanding evidence
Why a purity percentage, a content figure and an activity result answer separate questions , with worked illustrative examples showing how they can disagree.
Understanding evidence
A repeatable five-step audit for tracing a peptide claim back to its evidence, with worked illustrative examples of how claims drift.
Documentation
A reusable record layout for keeping the three descriptions of the same material , listing, label and report , aligned, with unknowns recorded as unknown.
Documentation
How milligrams per millilitre is calculated, how a target sample amount becomes a volume, and which assumptions the arithmetic does not make.
Research tool
Convert a total milligram amount and a final solution volume into milligrams per millilitre, then read the sample volume for a target amount in millilitres and microlitres, with an illustrated syringe schematic.
All guides are written by Bloom Labs and cite primary research or official product labelling. Published research describes compounds studied under laboratory or clinical conditions; it does not test materials sold for laboratory research use.
